| |
| |
|
| Insider
Information: |
Ballantyne Charles Evan |
| Relationship: |
Chief Financial Officer |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
34,795 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,547 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,795 |
|
|
| Total
Value |
$12,547 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
EVP, CFO |
2011-04-12 |
0 |
2006-08-21 |
0 |
Premium* |
|
|
Theriva Biologics Ord Shs |
TOVX |
Chief Financial Officer |
2014-05-22 |
10,000 |
2014-05-22 |
0 |
Premium* |
|
|
Antigenics Inc |
AGEN |
Chief Financial Officer |
2016-04-26 |
24,795 |
2015-09-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGEN |
Antigenics Inc |
Chief Financial Officer |
• – – |
2016-04-26 |
4/A |
D |
$4.15 |
$29,494 |
D/D |
(7,107) |
24,795 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Financial Officer |
• – – |
2016-04-26 |
4/A |
A |
$4.15 |
$90,893 |
D/D |
21,902 |
31,902 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Financial Officer |
• – – |
2016-04-26 |
4 |
D |
$4.15 |
$29,195 |
D/D |
(7,035) |
14,648 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Financial Officer |
• – – |
2016-04-26 |
4 |
A |
$4.15 |
$89,984 |
D/D |
21,683 |
21,683 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Financial Officer |
• – – |
2015-09-25 |
4 |
B |
$5.05 |
$50,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
Chief Financial Officer |
• – – |
2014-05-22 |
4 |
B |
$1.35 |
$13,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| CLDA |
Clinical Data Inc |
EVP, CFO |
• – – |
2011-04-12 |
4 |
D |
$30.00 |
$168,000 |
D/D |
(5,600) |
0 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
SVP, CFO |
• – – |
2007-12-14 |
4 |
B |
$22.00 |
$4,400 |
D/D |
200 |
5,600 |
2.66 |
- |
|
| CLDA |
Clinical Data Inc |
SVP, CFO |
• – – |
2007-12-14 |
4 |
B |
$21.28 |
$35,489 |
D/D |
1,650 |
5,400 |
2.74 |
- |
|
| CLDA |
Clinical Data Inc |
SVP, CFO |
• – – |
2007-09-06 |
4 |
B |
$26.28 |
$39,896 |
D/D |
1,500 |
2,500 |
2.74 |
- |
|
| CLDA |
Clinical Data Inc |
SVP, CFO |
• – – |
2006-12-11 |
4 |
B |
$16.79 |
$10,074 |
D/D |
600 |
1,000 |
2.74 |
- |
|
| CLDA |
Clinical Data Inc |
SVP, CFO |
• – – |
2006-08-21 |
4/A |
B |
$12.46 |
$4,984 |
D/D |
400 |
400 |
2.66 |
- |
|
| CLDA |
Clinical Data Inc |
SVP, CFO |
• – – |
2006-08-21 |
4 |
A |
$12.46 |
$4,984 |
D/D |
400 |
400 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
